Fifth Era Acquisition Corp I 3Q 2026: Net income $1.92M — 10-Q Summary

Fifth Era Acquisition Corp I reported a net income of $1.92M for 3Q 2026, up 106.5% YoY, driven by trust-account interest. The company expects its Miotal transaction to close in late 2026 or early 2027, with Miotal's strategic metals valued at $35B. As of September 30, 2026, the company had $133K in cash and a $4.3M working capital deficit. Nasdaq extended its compliance deadline to March 15, 2027.

Original reporting
Published Nov 13, 2026, 10:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Fifth Era Acquisition Corp I 3Q 2026: Net income $1.92M — 10-Q Summary — source image
Decision brief

The 30-second read

$FERANeutralLow
01

Why it matters

The filing offers the first public disclosure of Q3 results and compliance status, but the small financial figures limit trading relevance.

02

Market read

Micro‑cap SPAC earnings with compliance deadline; low trading relevance.

03

What to watch

Potential upside from the strategic metals assets valued at $35B, though not yet realized.

Relevance 4/10Novelty 4/10Timing: pre‑market today

Background

The article is an AI‑generated summary of Fifth Era Acquisition Corp I's 10‑Q filing, providing earnings, liquidity, and Nasdaq compliance details.

Company-level read

Ticker impact

$FERANeutralMedium confidence
Context

Fifth Era Acquisition Corp I filed its 10‑Q reporting Q3 2026 net income of $1.92M and disclosed a Nasdaq compliance deadline extension.

Expected impact

likely pressure as investors price in the risk of non‑compliance and the small scale of earnings

Evidence & confidence

Micro‑cap SPAC with minimal earnings and a working‑capital deficit; market typically reacts negatively to compliance concerns.

Market effects

Limited impact on the broader SPAC or acquisition sector due to the company's small size.

No significant regional effect; the filing is specific to the issuer.

Minimal global relevance.

Counterpoint

If the company successfully completes its business combination, the modest earnings could be a stepping stone to larger value.

Key entities

  • Fifth Era Acquisition Corp I

    SPAC listed on Nasdaq under ticker FERA.

Related articles

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

$YTRAMed

Yatra Online Inc (YTRA) (Q2 2027) Earnings Call Highlights: Air and Corporate Travel

Yatra Online (YTRA) reported Q2 2027 revenue from operations down 39% YoY to INR2,136M (~$22M) due to lower MICE volumes. Gross margin stayed flat at INR1,255M (~$13M). Adjusted EBITDA swung to negative INR32M (~negative $0.3M). CEO Gupta noted MICE recovery signs, TravelPro and Recap initiatives progress, and AI efficiency gains. Standalone hotels grew 20% YoY. H1 FY27 revenue declined 28% YoY to INR4,015M (~$42M).